RespiQ empowers people to take control of their wellbeing through early detection of health issues.
Founded in 2019 by focused, passionate and experienced health tech professionals, RespiQ is developing proven technology that provides accurate, cost-effective health testing at home.
Our mission is to positively impact the health of millions by providing accurate, non-invasive and affordable technology for early detection of health issues, breath by breath.
Our Team
Sarah van Hellenberg Hubar-Fisher
Strategic Advisor
New Business Development & Innovation Leader with 21 years of experience in strategic healthcare .
Advancing the fields of MedTech, HealthTech, and Global Public Health. With a proven track record in creating and executing new ventures, investments, innovation leadership and strategies, deal making and impact capital solutions across global markets.
Trang Anh Nguyen Le, PhD
MEMs & Microfabrication
Biomedical Engineer with an orientation on Nanotechnology.
Satadal Dutta, PhD
R&D Scientist
Research-driven Expert in semiconductor device physics, and optoelectronics, With a passion to make science and technology comprehensible for every human being.
Laura Verga, PhD
Scientist
Enthusiastic researcher and scientific writer, dedicated to advancing patient care and well-being
Chandan Sreedhara, MsC AI
Passionate about bridging the gap between research and application by building scalable AI models
Advisors & Partners
Prof. Anke-Hilse Maitland-van der Zee
partner P4O2 & Eurostars
Professor Precision Medicine in Pulmonary disease
Enthusiastic researcher with the main aim of bringing precision medicine to clinical practice. By using biomarkers instead of old fashioned diagnostic labels, goal is to optimise treatment for each individual patient with (respiratory) disease.
Anke-Hilse is leading a team of more than 40 researchers at the department of pulmonary disease in the Amsterdam UMC.
Prof. Mona Bafadhel
Advisor
Chair of Respiratory Medicine at King’s College London
Clinical Academic researcher with a PhD in Biomarkers of exacerbations of Chronic Obstructive Pulmonary Disease (COPD).
Mona is an international academic leader in respiratory medicine, with a passion for translating science to clinical practice to improve patients outcomes. Her work in COPD and COVID-19 has translated to changing clinical practice affecting millions across the world.
Prof. Han Gardeniers
Advisor
Professor at University of Twente, Faculty of Science and Technology, Mesoscale Chemical Systems
My general research interest is in micro and nanofabrication, applicable in the fields of chemistry and sustainable.
Prof. Paul Maguire
Advisor
Professor of Plasmas and Nanofabrication within the School of Engineering at Ulster University.
With a main research focus on the science and engineering of microplasmas at atmospheric pressure with particular interest in novel applications.
Diagnosing and monitoring health issue requires specific tests. These test are often invasive and time consuming. To make health testing more patient focused and accessible, we are developing a breath testing device that will be able to identify several health issues. The respiQ breathalyser allows for testing at home as well as point of care. This will empower individuals take control of their own wellbeing and will help specialist to manage their patients from a distance and intervene if necessary.
Our non-invasive hand-held device measures disease biomarkers in the breath to identify health issues. Our users will receive personalized health insights via our intuitive app. Our proprietary algorithm creates and analyses their digital breathprint, so people can continuously monitor changes to improve their health and wellbeing
This field is developing fast, and we plan to expand as we find opportunities that present the right combination of research maturity and social impact. Clinical research into breath diagnostics is currently showing promising results in detecting disease biomarkers, for illnesses including chronic respiratory disease, cancer and diabetes.